Lisa Murray‐Segal

772 total citations
26 papers, 542 citations indexed

About

Lisa Murray‐Segal is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Lisa Murray‐Segal has authored 26 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 10 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Lisa Murray‐Segal's work include Xenotransplantation and immune response (10 papers), Tissue Engineering and Regenerative Medicine (9 papers) and Pancreatic function and diabetes (9 papers). Lisa Murray‐Segal is often cited by papers focused on Xenotransplantation and immune response (10 papers), Tissue Engineering and Regenerative Medicine (9 papers) and Pancreatic function and diabetes (9 papers). Lisa Murray‐Segal collaborates with scholars based in Australia, United States and Canada. Lisa Murray‐Segal's co-authors include Peter J. Cowan, Bruce E. Kemp, Sandra Galić, Evelyn Salvaris, Gregory R. Steinberg, Kim Loh, Karen M. Dwyer, Harshal Nandurkar, Carly Selan and Anthony J.F. d’Apice and has published in prestigious journals such as Diabetes, International Journal of Molecular Sciences and Cell Reports.

In The Last Decade

Lisa Murray‐Segal

26 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Murray‐Segal Australia 12 276 196 78 73 62 26 542
Jorge Uribe United States 10 149 0.5× 416 2.1× 43 0.6× 30 0.4× 72 1.2× 15 814
Nadia Tinto Italy 15 250 0.9× 261 1.3× 194 2.5× 12 0.2× 81 1.3× 35 685
Yuko Miwa Japan 15 318 1.2× 172 0.9× 128 1.6× 8 0.1× 133 2.1× 36 701
Ming Wu China 12 197 0.7× 179 0.9× 15 0.2× 27 0.4× 43 0.7× 54 558
Natalia Shalbueva United States 6 432 1.6× 133 0.7× 49 0.6× 14 0.2× 99 1.6× 10 587
Cheng‐Chih Chung Taiwan 17 106 0.4× 324 1.7× 30 0.4× 14 0.2× 35 0.6× 45 811
Jingqiu Cui China 11 184 0.7× 148 0.8× 84 1.1× 15 0.2× 22 0.4× 43 491
Christopher M. Scull United States 6 93 0.3× 223 1.1× 20 0.3× 22 0.3× 130 2.1× 8 582
Petros Moustardas Greece 12 106 0.4× 88 0.4× 26 0.3× 8 0.1× 73 1.2× 20 453

Countries citing papers authored by Lisa Murray‐Segal

Since Specialization
Citations

This map shows the geographic impact of Lisa Murray‐Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Murray‐Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Murray‐Segal more than expected).

Fields of papers citing papers by Lisa Murray‐Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Murray‐Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Murray‐Segal. The network helps show where Lisa Murray‐Segal may publish in the future.

Co-authorship network of co-authors of Lisa Murray‐Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Murray‐Segal. A scholar is included among the top collaborators of Lisa Murray‐Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Murray‐Segal. Lisa Murray‐Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smiles, William J., Naomi X.Y. Ling, Ashfaqul Hoque, et al.. (2022). An AMPKα2-specific phospho-switch controls lysosomal targeting for activation. Cell Reports. 38(7). 110365–110365. 16 indexed citations
2.
Whitfield, Jamie, et al.. (2022). Disrupting AMPK-Glycogen Binding in Mice Increases Carbohydrate Utilization and Reduces Exercise Capacity. Frontiers in Physiology. 13. 859246–859246. 4 indexed citations
3.
Whitfield, Jamie, et al.. (2021). Mice with Whole-Body Disruption of AMPK-Glycogen Binding Have Increased Adiposity, Reduced Fat Oxidation and Altered Tissue Glycogen Dynamics. International Journal of Molecular Sciences. 22(17). 9616–9616. 7 indexed citations
4.
Hoffman, Nolan J., Jamie Whitfield, Sandra Galić, et al.. (2020). Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism. Molecular Metabolism. 41. 101048–101048. 32 indexed citations
5.
Galić, Sandra, Kim Loh, Lisa Murray‐Segal, et al.. (2018). AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis. eLife. 7. 77 indexed citations
6.
Dwyer, Karen M., Carly Selan, Susanna Freddi, et al.. (2017). CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages. Journal of Autoimmunity. 88. 131–138. 25 indexed citations
7.
Gock, Hilton, et al.. (2016). Human Endothelial Protein C Receptor Overexpression Protects Intraportal Islet Grafts in Mice. Transplantation Proceedings. 48(6). 2200–2207. 3 indexed citations
8.
Crikis, Sandra, B. Lu, Lisa Murray‐Segal, et al.. (2010). Transgenic Overexpression of CD39 Protects Against Renal Ischemia-Reperfusion and Transplant Vascular Injury. American Journal of Transplantation. 10(12). 2586–2595. 88 indexed citations
9.
Crikis, Sandra, Xiaomin Zhang, Karen M. Dwyer, et al.. (2010). Antiinflammatory and Anticoagulant Effects of Transgenic Expression of Human Thrombomodulin in Mice. American Journal of Transplantation. 10(2). 242–250. 32 indexed citations
10.
Murray‐Segal, Lisa, Hilton Gock, Peter J. Cowan, & Anthony J.F. d’Apice. (2008). Anti‐Gal antibody‐mediated skin graft rejection requires a threshold level of Gal expression. Xenotransplantation. 15(1). 20–26. 11 indexed citations
11.
Gock, Hilton, Lisa Murray‐Segal, Evelyn Salvaris, et al.. (2006). Cardiac and Skin Xenograft Survival in Different Recipient Mouse Strains. Transplantation. 82(10). 1362–1369. 3 indexed citations
12.
Crikis, Sandra, Karen M. Dwyer, Lisa Murray‐Segal, et al.. (2005). Transgenic Cd39 Expression Protects Against Renal Ischemia Reperfusion Injury.. Xenotransplantation. 12(5). 1 indexed citations
13.
Gock, Hilton, et al.. (2004). Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting gal-mediated skin graft rejection1. Transplantation. 77(5). 751–753. 21 indexed citations
14.
Chandra, Abhilash P., Evelyn Salvaris, Stacey N. Walters, et al.. (2004). Fate of αGal +/+ pancreatic islet grafts after transplantation into αGal knockout mice. Xenotransplantation. 11(4). 323–331. 9 indexed citations
15.
Gock, Hilton, et al.. (2002). gal mismatch alone causes skin graft rejection in mice1. Transplantation. 74(5). 637–645. 11 indexed citations
16.
Salvaris, Evelyn, Hilton Gock, Wenruo Han, et al.. (2000). Naturally acquired anti‐αGal antibodies in a murine allograft model similar to delayed xenograft rejection. Xenotransplantation. 7(1). 42–47. 11 indexed citations
17.
Gock, Hilton, Evelyn Salvaris, Lisa Murray‐Segal, et al.. (2000). Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Xenotransplantation. 7(4). 237–246. 15 indexed citations
18.
Gock, Hilton, Evelyn Salvaris, Wei Han, et al.. (2000). Anti–α1,3-Galactose–Mediated hyperacute rejection of vascularized transplants in a small animal model. Transplantation Proceedings. 32(7). 2075–2075. 2 indexed citations
19.
Mottram, Patricia L., et al.. (1999). Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts. Transplantation Proceedings. 31(1-2). 1414–1415. 1 indexed citations
20.
Pearse, Martin J., Ewa Witort, Patricia L. Mottram, et al.. (1998). ANTI-GAL ANTIBODY-MEDIATED ALLOGRAFT REJECTION IN ??1,3-GALACTOSYLTRANSFERASE GENE KNOCKOUT MICE. Transplantation. 66(6). 748–754. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026